The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs-Reference-Cited by-同舟云学术

The flavoprotein FOXRED2 reductively activates nitro-chloromethylbenzindolines and other hypoxia-targeting prodrugs

Published:2014-05 Issue:2 Volume:89 Page:224-235
ISSN:0006-2952
Container-title:Biochemical Pharmacology
language:en
Short-container-title:Biochemical Pharmacology

Author:

Hunter Francis W.,Jaiswal Jagdish K.,Hurley Daniel G.,Liyanage H.D. Sarath,McManaway Sarah P.,Gu Yongchuan,Richter Susan,Wang Jingli,Tercel Moana,Print Cristin G.,Wilson William R.,Pruijn Frederik B.

Publisher

Elsevier BV

Subject

Pharmacology,Biochemistry

Reference51 articles.

1. Targeting hypoxia in cancer therapy;Wilson;Nat Rev Cancer,2011

2. Tumour hypoxia, chemotherapeutic resistance and hypoxia-related therapies;Shannon;Cancer Treat Rev,2003

3. Hypoxia in cancer: significance and impact on clinical outcome;Vaupel;Cancer Metastasis Rev,2007

4. Molecular and cellular pharmacology of the hypoxia-activated prodrug TH-302;Meng;Mol Cancer Ther,2012

5. Mechanism of action and preclinical antitumor activity of the novel hypoxia-activated DNA cross-linking agent PR-104;Patterson;Clin Cancer Res,2007

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Knockdown of FOXRED2 restrains proliferation, invasion and migration of human melanoma cells;Heliyon;2023-12

2. Endoplasmic Reticulum Stress Could Predict the Prognosis of Cervical Cancer and Regulate the Occurrence of Radiation Mucositis;Dose-Response;2023-04

3. Development of a nitroreductase-dependent theranostic payload for antibody-drug conjugate;Bioorganic Chemistry;2022-12

4. Therapeutic targeting of the hypoxic tumour microenvironment;Nature Reviews Clinical Oncology;2021-07-29

5. Spatially-resolved pharmacokinetic/pharmacodynamic modelling of bystander effects of a nitrochloromethylbenzindoline hypoxia-activated prodrug;Cancer Chemotherapy and Pharmacology;2021-07-10